Serotypes responsible for invasive streptococcus pneumoniae infections among children in connecticut

Journal of Infectious Diseases

Volumn 169, Issue 1, 1994, Pages 212-214

  Shapiro, Eugene D ^a,b   Austrian, Robert ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Penn Travel Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONNECTICUT; FEMALE; HUMAN; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027957365     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.1.212     Document Type: Article

References (15)

1. Adams WG, Deaver KA, Cochi SL. et al. Decline of childhood Haemo philus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
2. Shapiro ED. Infections caused by Haemophilus influenzae type b: The beginning of the end? JAMA 1993;269:264-6.
3. Austrian R. Boettger C, Dole M, Fairly L, Fried M. Sirepiococeus pneu moniae type 16A. a hitherto undescribed pneumococcal type. J Clin Microbiol 1985;22:127-8.
4. Shapiro ED. Berg AT. Austrian R. Schroeder D, Parcells V, Margolis A. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
5. Giebink GS. Preventing pneumococcal disease in children: Recommendations for using pneumococcal vaccine. Pediatr Infect Dis 1985;4:343-8.
6. Austrian R. The Quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 1976;43:699-705.
7. Henrichsen J. The pneumococcal typing system and pneumococcal surveillance. J Infect 1979;I(suppl 2):31-7.
8. Robbins JB, Austrian R, Lee CJ. et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. Rev Infect Dis 1983;148:1136-59.
9. Gray BM. Dillon HC Jr. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis 1986;5:201-7.
10. Orange M. Gray BM. Pneumococcal serotypes causing disease in children in Alabama. Pediatr Infect Dis J 1993;12:244-6.
11. Austrian R. Preventing pneumococcal infection in Philadelphia. Philadelphia Med 1993;89:10-6.
12. Austrian R. Epidemiology of pneumococcal capsular types causing pediatric infections. Pediatr Infect Dis J 1989;8:S21-2.
13. Baltimore RS. New challenges in the development of a conjugate pneumococcal vaccine. JAMA 1992;268:3366-7.
14. Finland M. Barnes MW. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol 1977;5:154-66.
15. Keyserling HL, Anderson EL, Martin JL. Immunogenicity of a tetravalent (types 6B, 14, I9F, 23F) pneumococcal conjugate vaccine in infants [abstract 1016]. Pediatr Res 1993;33:172A.